Azza El-Remessy
8PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 11, 2022
Modulation of Mesenchymal Stem Cells for Enhanced Therapeutic Utility in Ischemic Vascular Diseases.Sally L Elshaer, Salma H Bahram, Pranav Rajashekar
|Jan 20, 2021
Modulation of p75<sup>NTR</sup> on Mesenchymal Stem Cells Increases Their Vascular Protection in Retinal Ischemia-Reperfusion Mouse Model.Sally L Elshaer, Hang-Soo Park, Laura Pearson
|Jun 05, 2020
Deletion of Thioredoxin-Interacting Protein (TXNIP) Abrogates High Fat Diet-induced Retinal Leukostasis, Barrier Dysfunction and Microvascular Degeneration in a Mouse Obesity Model.Islam N Mohamed, Nader Sheibani, Azza B El-Remessy
|Aug 25, 2019
Modulating Expression of Thioredoxin Interacting Protein (TXNIP) Prevents Secondary Damage and Preserves Visual Function in a Mouse Model of Ischemia/Reperfusion.Maha Coucha, Ahmed Y Shanab, Mohamed Sayed
|May 11, 2019
Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway.Sally L Elshaer, Abdulrahman Alwhaibi, Riyaz Mohamed
|Aug 23, 2018
Deletion of p75<sup>NTR</sup> prevents vaso-obliteration and retinal neovascularization via activation of Trk- A receptor in ischemic retinopathy model.Sally L Elshaer, Azza B El-Remessy
Pageof 2
